VRCA - Verrica Pharmaceuticals Inc.
5.31
0.110 2.072%
Share volume: 71,433
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$5.20
0.11
0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-13-2024 | 08-14-2024 | 11-04-2024 | 03-11-2025 | 05-13-2025 | 08-12-2025 | 11-14-2025 | |
| Assets | ||||||||
| Total Assets | 66.307 M | 52.010 M | 32.927 M | 54.134 M | 42.178 M | 39.107 M | 40.896 M | |
| Current Assets | 61.376 M | 47.318 M | 28.187 M | 51.179 M | 39.474 M | 36.781 M | 36.275 M | |
| Inventories | 2.499 M | 2.704 M | 2.584 M | 2.463 M | 2.459 M | 2.522 M | 2.304 M | |
| Other Current Assets | 2.344 M | 0.000 | 0.000 | 0.000 | 0.000 | 8.178 M | 1.959 M | |
| Short Term Investments | 2.344 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 7.594 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 48.939 M | 31.930 M | 22.959 M | 46.329 M | 29.595 M | 15.396 M | 21.097 M | |
| Total Non-current Assets | 4.931 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 937.000 K | 710.000 K | 651.000 K | 589.000 K | 537.000 K | 315.000 K | 225.000 K | |
| Other Assets | 3.994 M | 3.982 M | 4.089 M | 2.366 M | 2.167 M | 2.011 M | 4.396 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 66.307 M | 52.010 M | 32.927 M | 54.134 M | 42.178 M | 39.107 M | 40.896 M | |
| Total liabilities | 64.799 M | 65.310 M | 66.978 M | 63.994 M | 60.754 M | 56.591 M | 57.936 M | |
| Total current liabilities | 19.365 M | 20.051 M | 21.026 M | 29.012 M | 29.396 M | 29.222 M | 28.908 M | |
| Accounts Payable | 2.527 M | 1.150 M | 966.000 K | 1.896 M | 1.443 M | 2.321 M | 1.585 M | |
| Other liabilities | 0.000 | 744.000 K | 665.000 K | 3.231 M | 2.894 M | 2.791 M | 7.409 M | |
| Current long term debt | 1.010 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 45.434 M | 42.751 M | 43.305 M | 30.983 M | 27.809 M | 24.578 M | 21.619 M | |
| Other liabilities | 0.000 | 744.000 K | 665.000 K | 3.231 M | 2.894 M | 2.791 M | 7.409 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 1.508 M | -13.300 M | -34.051 M | -9.860 M | -18.576 M | -17.484 M | -17.040 M | |
| Common stock | 46.484 M | 254.665 M | 256.774 M | 297.167 M | 298.193 M | 299.081 M | 299.799 M | |
| Retained earnings | -250.779 M | -267.965 M | -290.825 M | -307.027 M | -316.769 M | -316.565 M | -316.839 M |